Hydroxyapatite carriers as drug eluting agents-An In Vitro analysis

Area of Science:

• Biomaterials Science
• Drug Delivery Systems
• Orthopedic Applications

Background:

• Hydroxyapatite (HA) based materials offer biocompatible and osteoconductive properties for drug delivery within the osseous skeleton.
• Customized drug carriers are essential for targeted delivery of pharmacologic agents.
• This study investigates the drug elution characteristics of HA granules.

Purpose of the Study:

• To quantify the drug-eluting properties of hydroxyapatite (HA) and silicon-substituted hydroxyapatite (HASi) beads.
• To evaluate the efficacy of these carriers for delivering specific antibiotics.
• To determine if eluted drug levels are sufficient for therapeutic effect.

Main Methods:

• HA and HASi beads were loaded with gentamicin, amoxicillin-clavulanate, and vancomycin.
• The loaded beads were divided into 5 experimental groups.
• Drug elution was quantified using UV spectrophotometry.

Main Results:

• All 5 groups demonstrated drug eluent levels significantly exceeding bactericidal concentrations.
• Consistent drug release profiles were observed across the different antibiotic-loaded HA and HASi groups.
• Spectrophotometric analysis confirmed the presence of therapeutic levels of antibiotics.

Conclusions:

• Hydroxyapatite (HA) and silicon-substituted hydroxyapatite (HASi) beads are effective drug delivery systems.
• These materials are viable options for clinicians seeking targeted drug delivery in orthopedic applications.
• The study supports the use of HA and HASi for localized antibiotic delivery to prevent or treat bone infections.